Prne
June 15th, 2009
PORTON DOWN, England - Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today it was issued European Patent EP1044283, which covers the use of endonuclease-based reporting in PCR and other nucleic acid amplification technologies. Becton, Dickinson and Company (BD) had filed a claim in opposition to this patent which was rejected by the European Patent Office at a proceeding in Munich on May 28.
The patent is part of a substantial portfolio of intellectual property exclusively licensed to Enigma Diagnostics by the Secretary of State for Defence. The technology involves the use of a thermostable endonuclease to cut a probe that recognises a specific sequence in the target amplification product. The system may be applied to a wide variety of molecular diagnostic applications including the rapid detection of viral and bacterial pathogens.
Enigma Diagnostics has developed products that completely automate the PCR process including sample extraction, amplification and analysis for application at the point-of-care by non-laboratory operators.
John McKinley, CEO of Enigma Diagnostics, stated: “The maintenance of this key patent secures and supports the further development of Enigma’s intellectual property portfolio.”
Contacts UK Contact: Enigma Diagnostics Deborah Cordingley deborah.cordingley@enigmadiagnostics.com +44-1980-590131 US Contact: Richard Lewis Communications, Inc. +1-212-827-0020 Gregory Tiberend - Media gtiberend@rlcinc.com Cecelia Heer - Investors cheer@rlcinc.com
About Enigma Diagnostics Limited
Enigma Diagnostics Limited is a private UK based company specialising in developing the next generation of rapid molecular diagnostic instrument platforms for decentralised and point-of-care settings.
Enigma’s innovative and proprietary technology combines the speed and sensitivity of real-time PCR (polymerase chain reaction) with the simplicity needed for field-based, decentralised and point-of-care tests providing results from a raw sample in less than 45 minutes.
The Company is targeting a number of multi-billion pound markets, core among which are the Clinical and high value Applied Markets. Enigma’s commercialisation strategy is to maximise revenues from a continuous flow of market leading rapid diagnostic point-of-care and in-field instrument and assay platforms, derived from its broad Intellectual Property portfolio of issued and filed patents. Enigma will partner with market leaders where global penetration of markets is required and where appropriate will build an in-house sales and marketing capability to direct distribution of its products.
Enigma has an exclusive licence from the Defence Science and Technology Laboratory to a portfolio of patents, which represent over 15 years of UK Ministry of Defence funded research and has licences from Applied Biosystems and Celera Licences for the commercialisation of real-time PCR instruments. Enigma’s R&D activities have generated a portfolio of over 50 plus worldwide patent families dedicated to real-time PCR and wider molecular technologies. Many of these patents are granted across a range of core commercial territories including US, EU and Japan with more extensive filing and grants across a number of other key territories.
For more information visit www.enigmadiagnostics.com
Source: Enigma Diagnostics Limited
UK Contact: Deborah Cordingley, Enigma Diagnostics, +44-1980-590131, deborah.cordingley at enigmadiagnostics.com, US Contact: Gregory Tiberend - Media, gtiberend at rlcinc.com, Cecelia Heer - Investors, cheer at rlcinc.com, both of Richard Lewis Communications, Inc., +1-212-827-0020
Filed under Health, Health Care / Hospitals, Pharmaceuticals | Tags: england, Enigma Diagnostics Limited, Porton down, United Kingdom | Comment Below
Related Press Releases SISVEL Announces Progress in the Formation of the DVB-T2 Patent PoolSeptember 13th, 2009 AMSTERDAM -
- Efforts of the Patent Owners directed to enabling an early and wide adoption of the DVB-T2 standard to the benefit of consumers and broadcasters
On the occasion of IBC2009 and ETSI approving the specification for the DVB-T2 Standard (ETSI EN 302 755), the most advanced technology for broadcasting digital TV on terrestrial networks, SISVEL announces that it has been coordinating meetings among owners of patent rights that have been evaluated as essential to the DVB-T2 standard by independent experts. The companies participating in these meetings are leading broadcasters, network operators, consumer electronics companies, R&D centers, as well as service providers and include: the British Broadcasting Corporation (BBC), DTVG Licensing (a subsidiary of DIRECTV), ETRI, France Telecom, TDF, LG Electronics, Nokia, Radiotelevisione Italiana (RAI), Samsung, SIDSA, and Telecom Bretagne. Patent Exploitation "Made in Germany"August 3rd, 2009 ST GEORGEN, Germany - Economic experts expect up to 35,000 business failures in Germany in 2009. Intangible assets such as patents are not sufficiently taken into account by many banks when making lending decisions. Enigma Diagnostics Announces Signing of Patent Licenses With Roche Molecular Systems, Inc.July 15th, 2009 PORTON DOWN, England -
Enigma Diagnostics Limited, the decentralized and point-of-care molecular diagnostics company, announced today that it has signed two patent license agreements with Roche Molecular Systems, Inc. (RMS). The licenses signed on 15 July 2009, provide Enigma full access under patents owned or licensed by RMS and its affiliates to practice HybProbe real-time PCR chemistry and melt analysis and will allow Enigma to commercialize HybProbe PCR tests for human and veterinary in vitro diagnostics on a worldwide basis. Enigma Diagnostics Announces Successful Evaluation of the Enigma FL by the UK's Veterinary Laboratories AgencyJune 29th, 2009 PORTON DOWN, England -
Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today successful independent testing for bovine viral diarrhoea (BVD) by the Veterinary Laboratories Agency to evaluate the performance of the Enigma FL (Field Laboratory). BVD is considered to be one of the main threats to cattle (1), affecting the majority of herds in the UK. /C O R R E C T I O N -- Enigma Diagnostics Limited/June 29th, 2009 PORTON DOWN, England - In the news release, "Enigma Diagnostics Announces Successful Evaluation of the Enigma FL by the UK's Veterinary Laboratories Agency" issued on 30 Jun 2009 13:17 GMT, by Enigma Diagnostics Limited over PR Newswire, we are advised by a representative of the company that a second footnote has been added at the end of the fourth paragraph. The note references the following link: enigmadiagnostics.com/template2.php?page=news.php&m=4
Complete, corrected release follows:
Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today successful independent testing for bovine viral diarrhoea (BVD) by the Veterinary Laboratories Agency to evaluate the performance of the Enigma FL (Field Laboratory). Finjan's Gateway Security Patent Receives Second Approval by US Patent OfficeJune 2nd, 2009 SAN JOSE, California - Finjan Inc., a leader in secure web gateway products and the provider of a unified web security solution for the enterprise market, announced today that the United States Patent and Trademark Office (PTO) has terminated the re-examination proceedings and issued a Notice of Intent to Issue Ex Parte Re-examination Certificate (Notice) in the re-examination of its U.S. Patent No. 6,092,194 for a system and method for protecting a computer and network from hostile downloadables. New Online Courses Cut Education Costs for Patent ProfessionalsMay 18th, 2009 ALEXANDRIA, Virginia - Patent Resources Group (PRG), the nation's leading patent educator, has launched a Video on Demand program that allows legal and business professionals to access patent courses and earn continuing legal education (CLE) or continuing professional development (CPD) credits online. (Logo: www.newscom.com/cgi-bin/prnh/20090413/PRGLOGO )
Video on Demand customers can take PRG's high-quality patent education courses at their own pace from any computer with Internet access, while eliminating the travel and hotel expenses associated with attending a classroom course. Copan and POCARED Diagnostics Partner to Enhance the Use of Liquid Based Microbiology and Introduce the Next Generation Microbiology SystemsMay 17th, 2009 BRESCIA, Italy - Alliance Aims to Develop Powerful Tools for Accurate and Rapid Microbiology Testing Leading to Improved Patient Outcomes
Under the partnership, the two companies will enhance the use of liquid based microbiology diagnostic products that incorporate Copan innovative collection and transport devices (like ESwab) for use in combination with POCARED's real-time quantification and identification platform. The Copan and POCARED partnership will also introduce a new level of automation and ease of use. Patent Searchers and Information Scientists Benefit from New Online ResourceApril 21st, 2009 ALEXANDRIA, Virginia - Intellogist Evaluates Search Tools and Shares Best Practices
Landon IP, Inc., the global leader in professional patent searching and analysis, has launched Intellogist, a free online tool that provides the intellectual property (IP) community with a revolutionary resource for finding objective information about patent searching tools and sharing best practices. (Logo: www.newscom.com/cgi-bin/prnh/20090413/LANDONLOGO )
Available today at www.intellogist.com, this website provides many resources for information scientists at companies and law firms, including:
-- Objective assessments of over 30 patent and non-patent search and analytics systems -- Side-by-side comparisons of key features of patent search systems -- Community-based best practices articles on patent searching tools and techniques -- Tool for identifying and linking to prior art resources by technical discipline -- Maps for finding patent search system coverage by country or viewing geographic coverage provided by each patent search system -- Tables showing data coverage provided by each system -- Discussion Forum for posting and answering search-related questions
Intellogist's capabilities will be invaluable to anyone involved in patent searching, whether they are identifying a system to use for a specific search or deciding what systems to purchase for their firm or company. US Patent Office Rejects 95% of Verathon Claims in Patent Case With Aircraft MedicalMarch 25th, 2009 EDINBURGH, Scotland - On March 23, 2009 the United States Patent and Trademark
Office ("USPTO") issued a Non-Final Action Closing Prosecution in the ongoing
re-examination of Verathon, Inc.'s United States Patent Number 6,543,447. Aircraft Medical, Ltd.
Related News Serverside Group granted second patent on core card customization architectureMay 21st, 2009 LONDON - Global technology provider, Serverside Group, announced that the Indian Patent Office has granted a patent directed to its core card customization architecture, thus establishing an international trend. Since the Indian filing was part of an international strategy, the grant of the Indian patent, which follows the grant of a European Patent, not only enhances Serverside's competitive position in India but indicates the likely outcome in other territories yet to come to grant. Judge dismisses Guardian Media's patent-infringement claim against NintendoJune 12th, 2009 Judge tosses patent claim against NintendoREDMOND, Wash. — A judge has dismissed a patent-infringement lawsuit against Nintendo over the company's Wii video game machine. Supreme Court to decide whether to limit 'business method' patentsJune 1st, 2009 Court to decide whether to limit patentsWASHINGTON — The Supreme Court has decided to take on an appeal that could decide whether someone can get a patent for a complex business idea. The high court on Monday decided to hear an appeal from Bernard Bilski and Rand Warsaw, who attempted to patent a method for managing weather-related risk having to do with trading in commodities. Judge rejects plaintiff's lawsuit against cup maker in first-of-its-kind patent caseJuly 8th, 2009 Judge closes door on legal quirk in patent lawALEXANDRIA, Va. — A federal judge has turned away a first-of-its-kind lawsuit filed by an attorney seeking to exploit a quirk in federal patent law that had been dormant for more than a century. Texas judge OKs patent judgment against Microsoft, tells it to stop selling Word in 60 daysAugust 13th, 2009 Microsoft ordered to pay $290M in patent rulingSEATTLE — A federal judge in Texas has ordered Microsoft Corp. to stop selling some versions of its Word software in the U.S. RI judge tosses $388 million patent infringement verdict against MicrosoftSeptember 30th, 2009 RI judge tosses patent verdict against MicrosoftSEATTLE — A federal judge in Rhode Island threw out a $388 million patent infringement jury verdict against Microsoft Corp., the latest move in a six-year legal skirmish. In April, a jury found that the world's largest software maker had infringed on a patent owned by Uniloc Inc. Michelle Obama's 'pricey' $5,950 clutch was actually worth a 'frugal' 875 dlrsJuly 10th, 2009 NEW YORK - Italian luxury goods manufacturer VBH has admitted that it had mistaken the clutch bag toted by U.S. First Lady Michelle Obama earlier this week while on a trip to Russia for its 5,950-dollar alligator manila bag. Judge upholds Merck patent on blockbuster allergy drug Singulair, protecting sales till 2012August 19th, 2009 Judge rules for Merck on allergy drug's patentTRENTON, N.J. — The patent for Merck & Co.'s blockbuster allergy and asthma drug is valid, a federal judge ruled Wednesday, handing the drugmaker a crucial victory in its 2 1/2-year legal battle to block a rival from selling a cheaper generic version. Indians get hot over Scottish bid to patent Chicken Tikka MasalaAugust 5th, 2009 LONDON - An attempt by a Pakistani-born British MP to patent the Chicken Tikka Masala as a dish of Scottish origin has fallen foul of Indian chefs and food experts. Labour MP Mohammed Sarwar has tabled an Early Day Motion in Britain's lower house of parliament claiming the Chicken Tikka Masala - once crowned Britain's national dish - originated in the Scottish city of Glasgow. Dish to pay TiVo $200 mln for violating injunction on technology that rewinds, pauses live TVSeptember 4th, 2009 Dish to pay TiVo $200 mln for injunction violationA federal judge on Friday ordered Dish Network Corp. and sister firm EchoStar Corp.
|
|
